Literature DB >> 10440871

Nuclear chromatin texture analysis of nonmalignant tissue can detect adjacent prostatic adenocarcinoma.

T Mairinger1, G Mikuz, A Gschwendtner.   

Abstract

BACKGROUND: The aim of this study was to investigate the possibility of identifying prostatic adenocarcinoma by nuclear chromatin texture feature analysis of adjacent histologically benign-looking tissue.
METHODS: Two hundred and forty prostatectomy specimens were selected from the archives of the Department of Pathology, University of Innsbruck. These consisted of 67 cases of benign prostatic hyperplasia (BPH) and 173 cases of prostatic adenocarcinoma (PAC). The specimen collection was divided randomly into a training set and test set. Cytospin preparations of disaggregated cells prepared from paraffin-embedded material were stained specifically for DNA by the Feulgen method. For the cancer cases, only tissue that histologically appeared nonmalignant, from the vicinity of the lesion, was used in the sample preparation. Only normal-appearing diploid cell nuclei were analyzed from both the BPH and PAC groups. A discriminator comprised of three nuclear texture features to separate BPH from PAC cases was derived from the training set of cases, and then applied to the independent test set cases.
RESULTS: PAC cases were separated from BPH cases with a sensitivity of 90% and a specificity of 97% on the independent test set of cases.
CONCLUSIONS: This retrospective investigation demonstrates that by high-resolution image cytometry it is possible to detect the presence of prostatic adenocarcinoma with very high reliability when examining prostate samples that only contain histologically normal-looking cells. This method could become clinically relevant in identification of cancers missed by histologically negative core needle biopsies. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440871     DOI: 10.1002/(sici)1097-0045(19990915)41:1<12::aid-pros3>3.0.co;2-#

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  15 in total

1.  Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometry.

Authors:  Vivek Nandakumar; Laimonas Kelbauskas; Roger Johnson; Deirdre Meldrum
Journal:  Cytometry A       Date:  2011-01       Impact factor: 4.355

2.  Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology.

Authors:  Ryan L Parr; Gabriel D Dakubo; Keith A Crandall; Jennifer Maki; Brian Reguly; Andrea Aguirre; Roy Wittock; Kerry Robinson; Jude S Alexander; Mark A Birch-Machin; Mamdouh Abdel-Malak; M Kent Froberg; Eleftherios P Diamandis; Robert E Thayer
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

Review 3.  The awakening of an advanced malignant cancer: an insult to the mitochondrial genome.

Authors:  Cody C Cook; Masahiro Higuchi
Journal:  Biochim Biophys Acta       Date:  2011-09-02

4.  Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.

Authors:  Michael C Risk; Beatrice S Knudsen; Ilsa Coleman; Ruth F Dumpit; Alan R Kristal; Nolwenn LeMeur; Robert C Gentleman; Lawrence D True; Peter S Nelson; Daniel W Lin
Journal:  Clin Cancer Res       Date:  2010-10-08       Impact factor: 12.531

5.  Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.

Authors:  Sachin Bhusari; Bing Yang; Jessica Kueck; Wei Huang; David F Jarrard
Journal:  Prostate       Date:  2011-03-22       Impact factor: 4.104

6.  In vivo nonmelanoma skin cancer diagnosis using Raman microspectroscopy.

Authors:  Chad A Lieber; Shovan K Majumder; Darrel L Ellis; D Dean Billheimer; Anita Mahadevan-Jansen
Journal:  Lasers Surg Med       Date:  2008-09       Impact factor: 4.025

Review 7.  Evidence for field cancerization of the prostate.

Authors:  Larisa Nonn; Vijayalakshmi Ananthanarayanan; Peter H Gann
Journal:  Prostate       Date:  2009-09-15       Impact factor: 4.104

8.  Markers of field cancerization: proposed clinical applications in prostate biopsies.

Authors:  Kristina A Trujillo; Anna C Jones; Jeffrey K Griffith; Marco Bisoffi
Journal:  Prostate Cancer       Date:  2012-05-14

9.  Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors.

Authors:  Uma R Chandran; Rajiv Dhir; Changqing Ma; George Michalopoulos; Michael Becich; John Gilbertson
Journal:  BMC Cancer       Date:  2005-05-13       Impact factor: 4.430

10.  Prognostic Value of Microvessel Density in Tumor and Peritumoral Area as Evaluated by CD31 Protein Expression and Argyrophilic Nucleolar Organizer Region Count in Endothelial Cells in Uterine Leiomyosarcoma.

Authors:  Ashot Avdalyan; Igor Bobrov; Vladimir Klimachev; Alexander Lazarev
Journal:  Sarcoma       Date:  2012-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.